- Home
- UIS vs ARCT Comparison
UIS vs ARCT Comparison
Compare UIS & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UIS
- ARCT
- Stock Information
- Founded
- UIS 1942
- ARCT 2013
- Country
- UIS United States
- ARCT United States
- Employees
- UIS N/A
- ARCT N/A
- Industry
- UIS EDP Services
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- UIS Technology
- ARCT Health Care
- Exchange
- UIS Nasdaq
- ARCT Nasdaq
- Market Cap
- UIS 271.5M
- ARCT 298.3M
- IPO Year
- UIS N/A
- ARCT N/A
- Fundamental
- Price
- UIS $4.75
- ARCT $12.91
- Analyst Decision
- UIS Hold
- ARCT Strong Buy
- Analyst Count
- UIS 1
- ARCT 8
- Target Price
- UIS $6.50
- ARCT $52.33
- AVG Volume (30 Days)
- UIS 735.5K
- ARCT 450.8K
- Earning Date
- UIS 04-30-2025
- ARCT 05-12-2025
- Dividend Yield
- UIS N/A
- ARCT N/A
- EPS Growth
- UIS N/A
- ARCT N/A
- EPS
- UIS N/A
- ARCT N/A
- Revenue
- UIS $1,952,700,000.00
- ARCT $143,680,000.00
- Revenue This Year
- UIS N/A
- ARCT N/A
- Revenue Next Year
- UIS $3.79
- ARCT $42.36
- P/E Ratio
- UIS N/A
- ARCT N/A
- Revenue Growth
- UIS N/A
- ARCT 15.38
- 52 Week Low
- UIS $3.32
- ARCT $8.04
- 52 Week High
- UIS $8.93
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- UIS 47.92
- ARCT 59.32
- Support Level
- UIS $4.71
- ARCT $11.51
- Resistance Level
- UIS $4.98
- ARCT $13.00
- Average True Range (ATR)
- UIS 0.22
- ARCT 0.99
- MACD
- UIS -0.08
- ARCT 0.12
- Stochastic Oscillator
- UIS 4.64
- ARCT 79.76
About UIS Unisys Corporation New
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.